Ranbaxy Laboratories Inc., Daiichi Sankyo generics news

Ranbaxy has temporarily suspended shipments of APIs from its facilities in Toansa and Dewas, India. Ranbaxy said the voluntary decision allows it to assess and review processes and controls. The company also formed a "Quality & Integrity Committee" to oversee manufacturing and quality control operations. Ranbaxy is majority owned by Daiichi. ...